Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Ashman

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Immunologic Research|October 6, 2007
Structural requirements and applications of inhibitory oligodeoxyribonucleotidesRobert F Ashman, Petar Lenert
Immunology|March 25, 2006
Extended sequence preferences for oligodeoxyribonucleotide activityPetar Lenert, Adam J Goeken, Robert F Ashman
International Immunopharmacology|March 8, 2011
Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9Robert F Ashman, J Adam Goeken, Petar S Lenert
Journal of Clinical Immunology|June 12, 2003
Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotidesPetar Lenert, Adam Goeken, Barry S Handwerger, et al.
International Immunology|March 12, 2011
Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 bindingRobert F Ashman, J Adam Goeken, Eicke Latz, et al.
Journal of Clinical Immunology|March 3, 2005
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 productionPetar Lenert, Rachel Brummel, Elizabeth H Field, et al.
DNA and Cell Biology|November 13, 2003
Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cellsPetar Lenert, Wendy Rasmussen, Robert F Ashman, et al.
International Immunology|March 5, 2005
Sequence requirements for oligodeoxyribonucleotide inhibitory activityRobert F Ashman, J Adam Goeken, Jennifer Drahos, et al.
Antisense & Nucleic Acid Drug Development|September 5, 2003
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cellsPetar Lenert, Ae-Kyung Yi, Arthur M Krieg, et al.
European Journal of Immunology|May 1, 2002
Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cellsLaura L Stunz, Petar Lenert, David Peckham, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Immunologic Research|October 6, 2007
Structural requirements and applications of inhibitory oligodeoxyribonucleotidesRobert F Ashman, Petar Lenert
Immunology|March 25, 2006
Extended sequence preferences for oligodeoxyribonucleotide activityPetar Lenert, Adam J Goeken, Robert F Ashman
International Immunopharmacology|March 8, 2011
Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9Robert F Ashman, J Adam Goeken, Petar S Lenert
Journal of Clinical Immunology|June 12, 2003
Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotidesPetar Lenert, Adam Goeken, Barry S Handwerger, et al.
International Immunology|March 12, 2011
Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 bindingRobert F Ashman, J Adam Goeken, Eicke Latz, et al.
Journal of Clinical Immunology|March 3, 2005
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 productionPetar Lenert, Rachel Brummel, Elizabeth H Field, et al.
DNA and Cell Biology|November 13, 2003
Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cellsPetar Lenert, Wendy Rasmussen, Robert F Ashman, et al.
International Immunology|March 5, 2005
Sequence requirements for oligodeoxyribonucleotide inhibitory activityRobert F Ashman, J Adam Goeken, Jennifer Drahos, et al.
Antisense & Nucleic Acid Drug Development|September 5, 2003
Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cellsPetar Lenert, Ae-Kyung Yi, Arthur M Krieg, et al.
European Journal of Immunology|May 1, 2002
Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cellsLaura L Stunz, Petar Lenert, David Peckham, et al.
Pageof 2